Vibrational Markovian modelling of footprints after the interaction of antibiotics with the packaging region of HIV type 1
From MaRDI portal
Publication:253465
DOI10.1016/S0092-8240(03)00064-8zbMATH Open1334.92232OpenAlexW2092057251WikidataQ44648537 ScholiaQ44648537MaRDI QIDQ253465FDOQ253465
Authors: Humberto González Díaz, Ronal Ramos de Armas, Reinaldo Molina 
Publication date: 8 March 2016
Published in: Bulletin of Mathematical Biology (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1016/s0092-8240(03)00064-8
Recommendations
- Modeling interactions between \(\mathrm{C}_{60}\) antiviral compounds and HIV protease
- HIV-1 integrase-DNA interactions investigated by molecular modelling
- Nucleotide's bilinear indices: novel bio-macromolecular descriptors for bioinformatics studies of nucleic acids. I: Prediction of paromomycin's affinity constant with HIV-1 \(\Psi\)-RNA packaging region
- Direct statistical modeling of HIV-1 infection based on a non-Markovian stochastic model
- Mathematical modeling of HIV-1 infection and drug therapy
Cited In (5)
- Simple stochastic fingerprints towards mathematical modeling in biology and medicine. II: Unifying Markov model for drugs side effects
- Alignment-free prediction of mycobacterial DNA promoters based on pseudo-folding lattice network or star-graph topological indices
- Nucleotide's bilinear indices: novel bio-macromolecular descriptors for bioinformatics studies of nucleic acids. I: Prediction of paromomycin's affinity constant with HIV-1 \(\Psi\)-RNA packaging region
- Use of linear regression model to compare RNA secondary structures
- Modeling interactions between \(\mathrm{C}_{60}\) antiviral compounds and HIV protease
This page was built for publication: Vibrational Markovian modelling of footprints after the interaction of antibiotics with the packaging region of HIV type 1
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q253465)
